Four-wavelength Time-resolved Optical Mammography in the 680-980-nm Range
Overview
Authors
Affiliations
What is to our knowledge the first instrument for time-resolved optical mammography operating at wave-lengths longer than 900 nm has been developed. It is a scanning system that relies on the acquisition of time-resolved transmittance curves at 683, 785, 912, and 975 nm, with a total measurement time of approximately 5 min for an entire image. Breast structures and lesions can be discriminated based on the different absorption and scattering properties at the four wavelengths, which reflect different contributions of oxyhemoglobin, deoxyhemoglobin, water, and lipids, as well as distinct structures. The system is currently used in a European clinical trial.
Study of Minor Chromophores in Biological Tissues by Diffuse Optical Spectroscopy (Review).
Bylinskaya K, Perekatova V, Turchin I Sovrem Tekhnologii Med. 2025; 17(1):146-162.
PMID: 40071075 PMC: 11892566. DOI: 10.17691/stm2025.17.1.12.
Advanced Optical Imaging-Guided Nanotheranostics towards Personalized Cancer Drug Delivery.
Murar M, Albertazzi L, Pujals S Nanomaterials (Basel). 2022; 12(3).
PMID: 35159744 PMC: 8838478. DOI: 10.3390/nano12030399.
Improving breast cancer diagnosis by reducing chest wall effect in diffuse optical tomography.
Zhou F, Mostafa A, Zhu Q J Biomed Opt. 2017; 22(3):36004.
PMID: 28253381 PMC: 5333769. DOI: 10.1117/1.JBO.22.3.036004.
Ban H, Schweiger M, Kavuri V, Cochran J, Xie L, Busch D Med Phys. 2016; 43(7):4383.
PMID: 27370153 PMC: 4920810. DOI: 10.1118/1.4953830.
A systematic review of the effects of diffuse optical imaging in breast diseases.
Akbari Sari A, Mobinizadeh M, Azadbakht M Iran J Cancer Prev. 2014; 6(1):44-51.
PMID: 25250109 PMC: 4142904.